Literature DB >> 6412270

The demethylation of amitriptyline: a cross-over study of steady-state plasma levels of amitriptyline and nortriptyline in depressed patients.

J E Burch.   

Abstract

Five elderly depressed patients were treated with amitriptyline (AT) and nortriptyline (NT) in turn, in a cross-over design. Steady-state plasma drug levels were compared with those calculated for eight healthy subjects of previous single-dose studies. Plasma clearances were on average about 2.5 times lower in the patients than the healthy subjects, but the ratios of the different reaction rates did not differ significantly between the two groups. The interpretation of the ratio of NT levels during AT treatment and NT treatment, in terms of the fraction of AT that is metabolised by demethylation, is discussed. The ratio of NT level to AT level during AT treatment was particularly variable between individuals. This was apparently due to independent variation in (a) the ratio of plasma clearances of AT and NT and (b) the fraction of AT metabolised to NT.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6412270     DOI: 10.1007/BF00436164

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  29 in total

1.  Sampling time, dosage schedule, and nortriptyline plasma levels.

Authors:  V E Ziegler; J W Knesevich; L T Wylie; J T Biggs
Journal:  Arch Gen Psychiatry       Date:  1977-05

2.  Influence of neuroleptics and benzodiazepines on metabolism of tricyclic antidepressants in man.

Authors:  L F Gram; K Overo; L Kirk
Journal:  Am J Psychiatry       Date:  1974-08       Impact factor: 18.112

3.  Clinical pharmacology. Possible clinical importance of genetic differences in drug metabolism.

Authors:  D W Nebert
Journal:  Br Med J (Clin Res Ed)       Date:  1981-08-22

4.  Nortriptyline in depressed patients with high plasma levels. II.

Authors:  R Braithwaite; S Montgomery; S Dawling
Journal:  Clin Pharmacol Ther       Date:  1978-03       Impact factor: 6.875

5.  Pharmacokinetics of single oral doses of nortriptyline in depressed elderly hospital patients and young healthy volunteers.

Authors:  S Dawling; P Crome; R Braithwaite
Journal:  Clin Pharmacokinet       Date:  1980 Jul-Aug       Impact factor: 6.447

6.  The practical significance of nortriptyline plasma control. A prospective evaluation under routine conditions in endogenous depression.

Authors:  B Sørensen; P Kragh-Sørensen; N E Larsen; E F Hvidberg
Journal:  Psychopharmacology (Berl)       Date:  1978-09-15       Impact factor: 4.530

7.  E- and Z-10-hydroxylation of nortriptyline: relationship to polymorphic debrisoquine hydroxylation.

Authors:  B Mellström; L Bertilsson; J Säwe; H U Schulz; F Sjöqvist
Journal:  Clin Pharmacol Ther       Date:  1981-08       Impact factor: 6.875

8.  A clinical trial comparing sustained release amitryptyline (Saroten Retard) and conventional amitriptyline tablets (Saroten) in endogenously depressed patients with simultaneous determination of serum levels of amitryptyline and nortriptyline.

Authors:  P Liisberg; H Mose; A Amdisen; A Jørgensen; H E Petersen
Journal:  Acta Psychiatr Scand       Date:  1978-05       Impact factor: 6.392

9.  On the relationship of nortriptyline: amitriptyline ratio to clinical improvement of amitriptyline treated depressive patients.

Authors:  G Jungkunz; H J Kuss
Journal:  Pharmakopsychiatr Neuropsychopharmakol       Date:  1980-05

10.  Pharmacokinetics of amitriptyline in the elderly.

Authors:  J F Henry; C Altamura; R Gomeni; M P Hervy; F Forette; P L Morselli
Journal:  Int J Clin Pharmacol Ther Toxicol       Date:  1981-01
View more
  1 in total

Review 1.  Pharmacokinetic Variability of Drugs Used for Prophylactic Treatment of Migraine.

Authors:  Peer Tfelt-Hansen; Frederik Nybye Ågesen; Agniezka Pavbro; Jacob Tfelt-Hansen
Journal:  CNS Drugs       Date:  2017-05       Impact factor: 5.749

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.